Carlos Balmaceda

563 total citations
30 papers, 278 citations indexed

About

Carlos Balmaceda is a scholar working on Economics and Econometrics, General Health Professions and Oncology. According to data from OpenAlex, Carlos Balmaceda has authored 30 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 5 papers in General Health Professions and 5 papers in Oncology. Recurrent topics in Carlos Balmaceda's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (5 papers) and Musculoskeletal pain and rehabilitation (4 papers). Carlos Balmaceda is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (5 papers) and Musculoskeletal pain and rehabilitation (4 papers). Carlos Balmaceda collaborates with scholars based in Chile, United Kingdom and Australia. Carlos Balmaceda's co-authors include Manuel Espinoza, Gareth I. Owen, Mauricio P. Pinto, Pedro Zitko, María Loreto Bravo, Carolina Ibáñez, Sumie Kato, Mauricio Cuello, Juan Carlos Roa and Fabricio Medina-Bolívar and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and BMC Public Health.

In The Last Decade

Carlos Balmaceda

26 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Balmaceda Chile 7 59 54 49 48 39 30 278
Uche Anadu Ndefo United States 10 21 0.4× 91 1.7× 88 1.8× 86 1.8× 9 0.2× 21 447
Øyvind Melien Norway 11 32 0.5× 22 0.4× 125 2.6× 31 0.6× 82 2.1× 25 401
Joanne Lester United States 10 18 0.3× 158 2.9× 97 2.0× 8 0.2× 8 0.2× 21 452
Jung‐Nien Lai Taiwan 11 44 0.7× 30 0.6× 70 1.4× 27 0.6× 5 0.1× 31 415
Lesley Dunfield Canada 8 8 0.1× 147 2.7× 131 2.7× 15 0.3× 30 0.8× 12 487
Jairo Hernández Spain 11 20 0.3× 6 0.1× 71 1.4× 46 1.0× 16 0.4× 26 383
Xiaomeng Liu China 10 15 0.3× 60 1.1× 36 0.7× 17 0.4× 7 0.2× 33 289
D. Parkin United Kingdom 10 25 0.4× 41 0.8× 66 1.3× 10 0.2× 5 0.1× 15 398
Greg Anglin United States 12 109 1.8× 114 2.1× 142 2.9× 32 0.7× 26 0.7× 21 1.2k
Murat Uçar Türkiye 9 11 0.2× 41 0.8× 29 0.6× 12 0.3× 10 0.3× 31 288

Countries citing papers authored by Carlos Balmaceda

Since Specialization
Citations

This map shows the geographic impact of Carlos Balmaceda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Balmaceda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Balmaceda more than expected).

Fields of papers citing papers by Carlos Balmaceda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Balmaceda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Balmaceda. The network helps show where Carlos Balmaceda may publish in the future.

Co-authorship network of co-authors of Carlos Balmaceda

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Balmaceda. A scholar is included among the top collaborators of Carlos Balmaceda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Balmaceda. Carlos Balmaceda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balmaceda, Carlos, Fazila Zulfiqar, Pankaj Pandey, et al.. (2025). Enhanced Production of Anti-Inflammatory and Antibacterial Prenylated Isoflavonoids in Pigeon Pea (Cajanus cajan) Hairy Root Cultures. Journal of Agricultural and Food Chemistry. 73(10). 5996–6009.
2.
Espinoza, Manuel, et al.. (2023). Estimation of the demand for palliative care in non-oncologic patients in Chile. BMC Palliative Care. 22(1). 5–5. 8 indexed citations
3.
Balmaceda, Carlos, et al.. (2023). Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile. Value in Health Regional Issues. 35. 69–77. 6 indexed citations
4.
Mondaca, Sebastián, Mauricio P. Pinto, José Peña, et al.. (2023). Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study. Value in Health Regional Issues. 35. 13–18.
5.
6.
Espinoza, Manuel, et al.. (2022). El costo esperado de cáncer en Chile. Revista médica de Chile. 150(11). 1438–1449. 3 indexed citations
7.
8.
Aceituno, David, et al.. (2022). Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis. Value in Health Regional Issues. 34. 14–22. 6 indexed citations
9.
10.
Zitko, Pedro, et al.. (2021). Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile. BMC Public Health. 21(1). 937–937. 15 indexed citations
11.
12.
13.
14.
15.
Espinoza, Manuel, et al.. (2018). Out-of-Pocket Expenditures in Health and Medications in Chile: Comparative Analysis Between 1997, 2007, and 2012. Value in Health Regional Issues. 17. 202–209. 5 indexed citations
16.
Balmaceda, Carlos, et al.. (2016). Cost Effectiveness of Nivolumab for the Treatment of Metastatic Melanoma in Chile. Value in Health. 19(7). A740–A740. 1 indexed citations
17.
18.
Balmaceda, Carlos, et al.. (2016). Cost Effectiveness of Ruxolitinib Versus Best Available Therapy For The Treatment of Myelofibrosis From Public Health Perspective In Chile. Value in Health. 19(7). A590–A590. 2 indexed citations
19.
20.
Balmaceda, Carlos, Manuel Espinoza, & Janepsy Díaz. (2015). Impacto de una Política de Equivalencia Terapéutica en el Precio de Medicamentos en Chile. Value in Health Regional Issues. 8. 43–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uche Anadu Ndefo Breakdown of academic impact, for papers by Øyvind Melien Breakdown of academic impact, for papers by Joanne Lester Breakdown of academic impact, for papers by Jung‐Nien Lai Breakdown of academic impact, for papers by Lesley Dunfield Breakdown of academic impact, for papers by Jairo Hernández Breakdown of academic impact, for papers by Xiaomeng Liu Breakdown of academic impact, for papers by D. Parkin Breakdown of academic impact, for papers by Greg Anglin Breakdown of academic impact, for papers by Murat Uçar
Rankless by CCL
2026